+73.5%
CSX vs GSK
+67.2%
+6.3%
-29.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.2% | -0.6% | +1.8% | +1.3% |
| 7D | +0.7% | +5.2% | -4.5% | 0.0% |
| 30D | +8.1% | +10.2% | -2.1% | +6.6% |
| 3M | +2.2% | -0.9% | +3.1% | +2.2% |
| 6M | +14.6% | +3.5% | +11.1% | +13.8% |
| YTD | +42.2% | +7.2% | +35.0% | +40.8% |
| 1Y | +47.3% | +12.0% | +35.3% | +45.2% |
| 3Y | +73.5% | +67.3% | +6.2% | +51.6% |
| All | +73.5% | +67.2% | +6.3% | +51.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling